J 2023

Cognitive Functions, Depressive and Anxiety Symptoms After One Year of CPAP Treatment in Obstructive Sleep Apnea

VANEK, Jakub, Jan PRASKO, Samuel GENZOR, Kamila BELOHRADOVA, Jozef VISNOVSKY et. al.

Základní údaje

Originální název

Cognitive Functions, Depressive and Anxiety Symptoms After One Year of CPAP Treatment in Obstructive Sleep Apnea

Autoři

VANEK, Jakub (203 Česká republika), Jan PRASKO (203 Česká republika, garant), Samuel GENZOR (203 Česká republika), Kamila BELOHRADOVA (203 Česká republika), Jozef VISNOVSKY (203 Česká republika), Jan MIZERA (203 Česká republika), Jonas BOCEK (203 Česká republika), Milan SOVA (203 Česká republika, domácí) a Marie OCISKOVA (203 Česká republika)

Vydání

Psychology Research and Behavior Management, ALBANY, DOVE MEDICAL PRESS LTD, 2023, 1179-1578

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Nový Zéland

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.300 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133291

Organizační jednotka

Lékařská fakulta

UT WoS

001019850700001

Klíčová slova anglicky

obstructive sleep apnoea; depression; cognitive functions; CPAP treatment; treatment efficacy; Trail Making Test; Verbal; Fluency Test

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 29. 1. 2024 12:42, Mgr. Tereza Miškechová

Anotace

V originále

Objective: The study worked with depressive symptoms, anxiety score and cognitive functions in obstructive sleep apnea (OSA) patients treated with CPAP.Methods: Eighty-one subjects with OSA and without psychiatric comorbidity were treated with CPAP for one year and completed the following scales and cognitive tests: Trail Making Test, Verbal Fluency Test, d2 Test, Beck Depression Inventory-II and Beck Anxiety Inventory. MINI ruled out psychiatric disorder. At the two months check-up, subjects were re-evaluated for depressive and anxiety symptoms, and after one year of CPAP treatment, subjects repeated cognitive tests and scales. Data about therapy adherence and effectiveness were obtained from the patient's CPAP machines. Results: The study was completed by 59 CPAP adherent patients and eight non-adherent patients. CPAP therapy effectiveness was verified in all patients by decreasing the apnea-hypopnoea index below 5 and/or 10% of baseline values. The adherent patients significantly improved depressive and anxiety symptoms. There was also an improvement in overall performance in the attention test; however, performance in many individual items did not change. The adherent patients also improved verbal fluency and in the Part B of the Trail making test. The non-adherent group significantly increased the number of mistakes made in the d2 test; other resultsConclusion: According to our results, OSA patients' mood, anxiety and certain cognitive domains improved during the one-year therapy with CPAP.